default author photo

Seok Jin Kim

Sungkyunkwan University - Division of Hematology-Oncology

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

3

DOWNLOADS

258

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Efficacy of Intravenous Iron Replacement for Chemotherapy-Induced Anemia: A Prospective Phase II Pilot Study

Number of pages: 34 Posted: 03 Jun 2019
Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Catholic University of Korea - Department of Hematology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 158 (472,207)

Abstract:

Loading...

2.

Comprehensive Analysis of Peripheral T-Cell and Natural Killer/T-Cell Lymphoma in Asian Patients: A Multinational, Multicenter, Prospective Registry Study in Asia

Number of pages: 45 Posted: 17 Dec 2020
Sungkyunkwan University - Samsung Medical Center, Peking University - Peking University Cancer Hospital & Institute, Sungkyunkwan University - Division of Hematology-Oncology, University of Ulsan - Department of Oncology, National Cheng Kung University - Division of Hematology and Oncology, Seoul National University - Department of Internal Medicine, Anam Hospital Korea University Medical Center - Department of Internal Medicine, Division of Hematology-Oncology, Kosin University Gospel Hospital, Department of Internal Medicine, Chungnam National University College of Medicine, Chinese Academy of Medical Sciences - National Cancer Center, Department of Haematology-Oncology, National University Health System, University of Indonesia (UI), Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Keimyung University - Dongsan Medical Center, Department of Hematology-Oncology, Konkuk University Medical Center, Subang Jaya Medical Center, Division of Hemato-Oncology, Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Fudan University Shanghai Cancer Center, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Korea Institute of Radiological and Medical Sciences, Department of Internal Medicine, Chungnam National University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Raffles Cancer Centre, Division of Hematology–Oncology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University, Department of Hematology and Medical Oncology, College of Medicine, Kyung Hee University, Division of Hematology–Oncology, Ewha Womans University Mokdong Hospital, Ewha Womans University, Dong-A University, School of Medicine, Dong-A University Hospital, Department of Internal Medicine, Department of Internal Medicine, Wonkwang University School of Medicine, Chungnam National University, Inje University - Department of Medicine, Department of Internal Medicine, Soonchunhyang University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Sungkyunkwan University - Samsung Medical Center, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 54 (1,020,567)

Abstract:

Loading...

Lymphoma, T-Cell, Peripheral; Lymphoma, Extranodal NK-T-Cell; Incidence; Therapeutics; Survival; Prognosis

3.

Phase II Brentuximab Vedotin Trial for Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas

Number of pages: 82 Posted: 21 Feb 2019
Sungkyunkwan University - Division of Hematology-Oncology, University of Ulsan - Department of Oncology, Yonsei University - Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, National Cancer Center, Korea, National Cancer Center, Korea, University of Ulsan - Department of Oncology, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, University of Ulsan - Asan Medical Center, Yonsei University - College of Medicine, National Cancer Center, Korea, Korea Institute of Radiological and Medical Sciences, University of Ulsan - Department of Oncology and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 46 (1,121,190)

Abstract:

Loading...

Brentuximab, non-Hodgkin lymphoma, CD30, Epstein-Barr virus, multiple myeloma oncogene-1